Podcast
Expert Insights on Highlights From ASH 2020 on Lymphomas/CLL

Released: March 26, 2021

Expiration: March 25, 2022

Jeremy S Abramson
Jeremy S Abramson, MD, MMSc

Activity

Progress
1
Course Completed

In this episode, Jeremy S. Abramson, MD, MMSc, discusses highlights of the key data from ASH 2020 on the treatment of patients with lymphomas/CLL, with topics including:

  • Approved and Investigational Targeted Therapeutics for CLL
  • Investigational CAR T-Cell Therapy for Indolent Lymphomas, CLL, and Mantle Cell Lymphoma
  • Bispecific Antibodies and Other Investigational Targeted Agents for Lymphomas
  • Treatment for Older Patients With Hodgkin Lymphoma

Presenters:

Jeremy S. Abramson, MD, MMSc
Associate Professor  
Department of Medicine  
Harvard Medical School  
Director, Center for Lymphoma  
Massachusetts General Hospital  
Boston, Massachusetts